HPV Self-Sampling for Cervical Cancer Screening Among Lesbian, Bisexual, and Queer (LBQ) Women

Not Applicable

Completed

• Conditions: Cervical Cancer Screening
• Interventions: Behavioral: HPV self-sampling

• Registration Number: NCT03012932
• Lead Sponsor: University of Miami

Brief Summary

The proposed study will examine the implementation of a Human Papilloma Virus (HPV) self-sampling intervention for under screened LBQ women living in South Florida. The study will enroll participants to receive the self-sampling intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2017-01-03
• Study First Submitted QC: 2017-01-04
• Study First Posted: 2017-01-06
• Study Start: 2017-02-02
• Primary Completion: 2018-03-24
• Study Completion: 2018-03-24
• Status Verified: 2018-09
• Last Update Submitted: 2018-09-24
• Last Update Posted: 2018-09-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 10

Inclusion Criteria

• Self-identify as lesbian, bisexual, or queer woman
• Assigned female sex at birth
• English speaking
• ages 25-65 years
• report not having had a pap smear in the last three years (per USPSTF guidelines)
• if age 30 or over, report not having a pap smear/HPV co-test within the past 5 years (per USPSTF guidelines)

Read More

Exclusion Criteria

• report having had a hysterectomy
• report having history of cervical cancer
• unable to consent
• Pregnant women
• Prisoners

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
HPV Self-sampling	HPV self-sampling	All participants will receive HPV self-sampling intervention. HPV self-sampling is a cervical cancer screening that can be done in private, using a device that is similar to a tampon. This intervention tests for high-risk HPV, the primary cause of cervical cancer. Each participant will complete the intervention one time only.

Primary Outcome Measures

Name	Time	Method
HPV Self-sampling uptake	through study completion, up to 1 year	Percentage of eligible women who complete HPV self-sampling

Trial Locations

Locations (1)

University of Miami; 🇺🇸 Miami, Florida, United States